First human test: how kidneys affect new drug
NCT ID NCT07426380
Summary
This is an early safety study to see how a new drug called Eloralintide moves through the body in people with severe kidney disease. Researchers will compare results from 28 participants—some with healthy kidneys and some with severe kidney impairment. The main goal is to understand how the drug is processed and if it is safe for people whose kidneys don't work well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Floridian Clinical Research, LLC
RECRUITINGMiami Lakes, Florida, 33016-1518, United States
Contact Phone: •••-•••-••••
Contact
-
Omega Research Orlando LLC
RECRUITINGOrlando, Florida, 32808, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.